Contact Lenses News:
ARLINGTON, Va.—The Health Care Alliance for Patient Safety, a newly formed policy advancement and information organization that includes executives from the eye health community, will hold a congressional briefing at noon on Tuesday, April 24, in Washington, D.C. The one-hour session, which will be held in room 2247 of The Rayburn House Office Building, will address “the importance of protecting the safety of patients who use contact lenses, which are regulated medical devices,” according to an ...
NEW BRUNSWICK, N.J.—Johnson & Johnson reported that its first-quarter sales increased 12.6 percent to $20.0 billion, with growth across all three of its sectors....
WALTHAM, Mass.—EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG) reported this week that the U.S. Patent and Trademark Office has issued the company a patent covering the utility of its iontophoretic contact lens. EyeGate is a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for treating diseases and disorders of the eye. The U.S. patent, entitled “Iontophoretic Contact Lens,” was issued on April 10, according to an EyeGate announcement. EyeGate said this is t...
JACKSONVILLE, Fla.—Johnson & Johnson Vision reported that it has developed a “first-of-its-kind contact lens that provides wearers with vision correction and a dynamic photochromic filter” that adapts to changing light conditions....
NORWALK, Conn.—IDOC, a privately held alliance of independent optometrists, is launching a “Satisfaction Guarantee” program that allows independent OD’s to take full advantage of an IDOC membership program risk-free, according to an announcement Monday. If a member is not completely satisfied with their IDOC membership, their dues will be refunded in full if all conditions of the offer are met, the announcement noted. “At IDOC, we’re so confident that OD’s will see their membership positively im...
FORT WORTH, Texas—Novartis AG (NYSE: NVS) is holding steady on its commitment to continue an ongoing review of growth trends at its Alcon eyecare unit before making a decision on a potential sale or spinoff of the business in the first half of 2019, according to a news report this week. The company’s new chief executive officer, Vasant Narasimhan, reiterated the company’s previously announced plans for Alcon in an interview with CNBC at the China Development Forum. Joe Jimenez, who had been chie...